Perfect Pitch: Rheos Raises $60m To Tune Immune Cells In Autoimmune Diseases

The Third Rock Ventures-funded start-up Rheos Medicines raised a $60m Series A round to study immune cell metabolism for drug targets that allow the company to fine-tune the immune system in autoimmune and inflammatory diseases, as well as cancer.